Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?

Hyaluronidase is currently not included into Russian or foreign guidelines on the treatment of acute respiratory distress-syndrome in patients with COVID-19, and such treatment is not supported by evidence of clinical effectiveness. Hyaluronidase can only be used for COVID-19 within clinical trials.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yu. Yu. Kiselev (Auteur), K. B. Mirzaev (Auteur), D. A. Sychev (Auteur)
Format: Livre
Publié: Izdatelstvo OKI, 2020-10-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible